AGP Picks
View all

Iowa Healthcare Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Iowa Healthcare Reporter.

Press releases published on September 28, 2026

Zealand Pharma - Transactions related to share buy-back program (week 39, 2026)
NTHU Becomes First in Taiwan to Successfully Treat Breast Cancer with BNCT, Achieving Significant Tumor Reduction
Liquid Biopsy with Emphasis on Cancer Market to Reach $8.0 Billion by 2031, Driven by Rising Cancer Incidence and Precision Medicine Adoption
Powerful NeOnc Brain Cancer Pipeline Advances
Novonesis celebrates major expansion of West Allis production facility, strengthening North American dairy innovation and manufacturing
MindRank Partners with 3SBio to Commercialize its AI-Designed Oral GLP-1 in China
Oncolytics Biotech® Reports Accelerating Enrollment in Randomized REO 033 RAS-Mutant, MSS Colorectal Cancer Study
EnerSyn Global Inc. Announces Second Nigeria Energy Investment: Lagos CNG Mother Station Project
Hyperion DeFi Supports D3’s Frontier Vault Launch, Bringing Internet Domain Priority Access to the Hyperliquid Ecosystem
CapsoVision Announces FDA Clearance of AI Highlights for CapsoCam Plus®
Palisade Bio to Present Clinical and Translational Data for PALI-2108 in Ulcerative Colitis and Crohn’s Disease at UEG Week 2026
Lifecore Biomedical to be Acquired by Webster Equity Partners
GRI Bio to Highlight Immune Modulation and Phase 2a Development Insights in IPF at the 10th IPF Summit
Silexion Therapeutics Reports Positive Preclinical Findings for SIL204, Demonstrating Key Mechanism for Endogenous Systemic Uptake in KRAS-Driven Cancers
Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026
Carlsmed Appoints Richard Heppenstall as Chief Financial Officer
DLH Awarded New NIH Cybersecurity Operations Task Order Valued at Up to $19.1 Million
Dare Bioscience Announces New U.S. Patent Strengthening DARE-HPV Program as a Potential First FDA-Approved Pharmacologic Treatment for HPV Infection
 Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research
Keros Therapeutics Announces the First Patient Dosing in the Phase 2 Clinical Trial Evaluating Rinvatercept in DMD

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Iowa Healthcare Reporter

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.